15-71215215-G-A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_024817.3(THSD4):c.280G>A(p.Gly94Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000646 in 1,377,854 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. G94G) has been classified as Benign.
Frequency
Consequence
NM_024817.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THSD4 | NM_024817.3 | c.280G>A | p.Gly94Ser | missense_variant | 4/18 | ENST00000261862.8 | |
THSD4 | NM_001394532.1 | c.280G>A | p.Gly94Ser | missense_variant | 4/18 | ||
THSD4 | XM_047433080.1 | c.280G>A | p.Gly94Ser | missense_variant | 4/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THSD4 | ENST00000261862.8 | c.280G>A | p.Gly94Ser | missense_variant | 4/18 | 5 | NM_024817.3 | P1 | |
THSD4 | ENST00000355327.7 | c.280G>A | p.Gly94Ser | missense_variant | 4/18 | 5 | P1 | ||
THSD4 | ENST00000620694.1 | c.280G>A | p.Gly94Ser | missense_variant | 4/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000462 AC: 7AN: 151584Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000219 AC: 7AN: 31982Hom.: 0 AF XY: 0.000258 AC XY: 5AN XY: 19390
GnomAD4 exome AF: 0.0000669 AC: 82AN: 1226162Hom.: 1 Cov.: 31 AF XY: 0.0000833 AC XY: 50AN XY: 600528
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151692Hom.: 0 Cov.: 33 AF XY: 0.0000540 AC XY: 4AN XY: 74138
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at